Trust Co. of Vermont Has $9.28 Million Position in Church & Dwight Co., Inc. $CHD

Trust Co. of Vermont lowered its position in Church & Dwight Co., Inc. (NYSE:CHD) by 0.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 96,524 shares of the company’s stock after selling 900 shares during the quarter. Trust Co. of Vermont’s holdings in Church & Dwight were worth $9,277,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Pacific Point Advisors LLC lifted its stake in Church & Dwight by 5.7% in the second quarter. Pacific Point Advisors LLC now owns 14,059 shares of the company’s stock valued at $1,351,000 after acquiring an additional 760 shares during the last quarter. LBP AM SA acquired a new stake in Church & Dwight in the second quarter valued at $19,376,000. Paradiem LLC acquired a new stake in Church & Dwight in the second quarter valued at $1,441,000. GC Wealth Management RIA LLC acquired a new stake in shares of Church & Dwight during the 2nd quarter worth about $210,000. Finally, Addenda Capital Inc. lifted its stake in shares of Church & Dwight by 2.2% during the 2nd quarter. Addenda Capital Inc. now owns 66,223 shares of the company’s stock worth $6,365,000 after buying an additional 1,406 shares during the last quarter. Institutional investors and hedge funds own 86.60% of the company’s stock.

Church & Dwight Price Performance

Shares of Church & Dwight stock opened at $87.67 on Wednesday. Church & Dwight Co., Inc. has a twelve month low of $85.08 and a twelve month high of $116.46. The company has a quick ratio of 1.33, a current ratio of 1.84 and a debt-to-equity ratio of 0.50. The company has a 50-day simple moving average of $92.59 and a two-hundred day simple moving average of $97.17. The stock has a market capitalization of $21.36 billion, a price-to-earnings ratio of 41.35, a price-to-earnings-growth ratio of 3.56 and a beta of 0.44.

Church & Dwight (NYSE:CHD) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.94 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.09. Church & Dwight had a net margin of 8.66% and a return on equity of 19.27%. The business had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter in the previous year, the company earned $0.93 EPS. The business’s revenue was down .3% on a year-over-year basis. Church & Dwight has set its FY 2025 guidance at 3.440-3.510 EPS. Q3 2025 guidance at 0.720-0.720 EPS. Analysts forecast that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 2nd. Shareholders of record on Friday, August 15th were issued a $0.295 dividend. This represents a $1.18 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend was Friday, August 15th. Church & Dwight’s dividend payout ratio (DPR) is currently 55.66%.

Insider Buying and Selling at Church & Dwight

In other news, CEO Richard A. Dierker bought 5,470 shares of the firm’s stock in a transaction on Tuesday, August 12th. The shares were purchased at an average cost of $91.57 per share, with a total value of $500,887.90. Following the acquisition, the chief executive officer directly owned 27,212 shares in the company, valued at $2,491,802.84. This represents a 25.16% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Lee B. Mcchesney bought 5,409 shares of the firm’s stock in a transaction on Friday, August 8th. The stock was purchased at an average cost of $91.38 per share, for a total transaction of $494,274.42. Following the completion of the acquisition, the executive vice president owned 5,409 shares in the company, valued at approximately $494,274.42. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 12,879 shares of company stock valued at $1,177,702 in the last ninety days. 1.20% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Rothschild & Co Redburn cut shares of Church & Dwight from a “neutral” rating to a “sell” rating and set a $83.00 target price for the company. in a research note on Monday, July 14th. UBS Group raised their target price on shares of Church & Dwight from $102.00 to $103.00 and gave the stock a “neutral” rating in a research note on Thursday, July 17th. Truist Financial set a $110.00 target price on shares of Church & Dwight and gave the stock a “buy” rating in a research note on Friday, June 6th. Barclays cut their target price on shares of Church & Dwight from $84.00 to $83.00 and set an “underweight” rating for the company in a research note on Monday, August 4th. Finally, Redburn Atlantic cut shares of Church & Dwight from a “hold” rating to a “strong sell” rating in a research note on Monday, July 14th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, Church & Dwight has a consensus rating of “Hold” and a consensus target price of $103.44.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.